Evaluation of renal function in transplant patients on tacrolimus therapy

Sangeeta Agarwala, Emma Culligan, Ashokkumar Jain, Jerry McCauley, Ron Shapiro, Pradip Chakrabarti, Gilbert Burckart, Raman Venkataramanan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Glomerular filtration rate (GFR), as measured by 24-hour creatinine clearance and clearance of iothalamate, and effective renal plasma flow (ERPF), as measured by the clearance of para-aminohippuric acid (PAH), were evaluated at 2 weeks, 1 month, and 3 months after transplantation in 8 renal transplant patients and at 1 month and 1 year after transplantation in 9 liver transplant patients receiving tacrolimus (Prograf®) therapy. In renal transplant patients, there was a significant increase in GFR after transplantation. There was no change in GFR at 1 and 3 months as compared to 2 weeks after transplantation, while ERPF (ml/min/1.73 m2) was lower (p < 0.05) at 3 months (212 ± 42) compared to 1 month (306 ± 118) after transplantation. In liver transplant patients, GFR and ERPF were below normal despite normal serum creatinine concentrations, but there was no difference in GFR or ERPF at 1 month and 1 year after transplantation. Although below normal, renal function was well preserved in transplant patients while receiving chronic tacrolimus therapy over the study period. Dosage alterations of renally eliminated drugs may be required for drugs with a narrow therapeutic index.

Original languageEnglish (US)
Pages (from-to)798-805
Number of pages8
JournalJournal of Clinical Pharmacology
Volume42
Issue number7
DOIs
StatePublished - Jul 2 2002

Fingerprint

Tacrolimus
Effective Renal Plasma Flow
Glomerular Filtration Rate
Transplantation
Transplants
Kidney
Creatinine
Therapeutics
Iothalamic Acid
p-Aminohippuric Acid
Liver
Pharmaceutical Preparations
Serum

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Agarwala, S., Culligan, E., Jain, A., McCauley, J., Shapiro, R., Chakrabarti, P., ... Venkataramanan, R. (2002). Evaluation of renal function in transplant patients on tacrolimus therapy. Journal of Clinical Pharmacology, 42(7), 798-805. https://doi.org/10.1177/009127002401102632
Agarwala, Sangeeta ; Culligan, Emma ; Jain, Ashokkumar ; McCauley, Jerry ; Shapiro, Ron ; Chakrabarti, Pradip ; Burckart, Gilbert ; Venkataramanan, Raman. / Evaluation of renal function in transplant patients on tacrolimus therapy. In: Journal of Clinical Pharmacology. 2002 ; Vol. 42, No. 7. pp. 798-805.
@article{2994a82a7a984ff29129ebd8330c9f91,
title = "Evaluation of renal function in transplant patients on tacrolimus therapy",
abstract = "Glomerular filtration rate (GFR), as measured by 24-hour creatinine clearance and clearance of iothalamate, and effective renal plasma flow (ERPF), as measured by the clearance of para-aminohippuric acid (PAH), were evaluated at 2 weeks, 1 month, and 3 months after transplantation in 8 renal transplant patients and at 1 month and 1 year after transplantation in 9 liver transplant patients receiving tacrolimus (Prograf{\circledR}) therapy. In renal transplant patients, there was a significant increase in GFR after transplantation. There was no change in GFR at 1 and 3 months as compared to 2 weeks after transplantation, while ERPF (ml/min/1.73 m2) was lower (p < 0.05) at 3 months (212 ± 42) compared to 1 month (306 ± 118) after transplantation. In liver transplant patients, GFR and ERPF were below normal despite normal serum creatinine concentrations, but there was no difference in GFR or ERPF at 1 month and 1 year after transplantation. Although below normal, renal function was well preserved in transplant patients while receiving chronic tacrolimus therapy over the study period. Dosage alterations of renally eliminated drugs may be required for drugs with a narrow therapeutic index.",
author = "Sangeeta Agarwala and Emma Culligan and Ashokkumar Jain and Jerry McCauley and Ron Shapiro and Pradip Chakrabarti and Gilbert Burckart and Raman Venkataramanan",
year = "2002",
month = "7",
day = "2",
doi = "10.1177/009127002401102632",
language = "English (US)",
volume = "42",
pages = "798--805",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "7",

}

Agarwala, S, Culligan, E, Jain, A, McCauley, J, Shapiro, R, Chakrabarti, P, Burckart, G & Venkataramanan, R 2002, 'Evaluation of renal function in transplant patients on tacrolimus therapy', Journal of Clinical Pharmacology, vol. 42, no. 7, pp. 798-805. https://doi.org/10.1177/009127002401102632

Evaluation of renal function in transplant patients on tacrolimus therapy. / Agarwala, Sangeeta; Culligan, Emma; Jain, Ashokkumar; McCauley, Jerry; Shapiro, Ron; Chakrabarti, Pradip; Burckart, Gilbert; Venkataramanan, Raman.

In: Journal of Clinical Pharmacology, Vol. 42, No. 7, 02.07.2002, p. 798-805.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of renal function in transplant patients on tacrolimus therapy

AU - Agarwala, Sangeeta

AU - Culligan, Emma

AU - Jain, Ashokkumar

AU - McCauley, Jerry

AU - Shapiro, Ron

AU - Chakrabarti, Pradip

AU - Burckart, Gilbert

AU - Venkataramanan, Raman

PY - 2002/7/2

Y1 - 2002/7/2

N2 - Glomerular filtration rate (GFR), as measured by 24-hour creatinine clearance and clearance of iothalamate, and effective renal plasma flow (ERPF), as measured by the clearance of para-aminohippuric acid (PAH), were evaluated at 2 weeks, 1 month, and 3 months after transplantation in 8 renal transplant patients and at 1 month and 1 year after transplantation in 9 liver transplant patients receiving tacrolimus (Prograf®) therapy. In renal transplant patients, there was a significant increase in GFR after transplantation. There was no change in GFR at 1 and 3 months as compared to 2 weeks after transplantation, while ERPF (ml/min/1.73 m2) was lower (p < 0.05) at 3 months (212 ± 42) compared to 1 month (306 ± 118) after transplantation. In liver transplant patients, GFR and ERPF were below normal despite normal serum creatinine concentrations, but there was no difference in GFR or ERPF at 1 month and 1 year after transplantation. Although below normal, renal function was well preserved in transplant patients while receiving chronic tacrolimus therapy over the study period. Dosage alterations of renally eliminated drugs may be required for drugs with a narrow therapeutic index.

AB - Glomerular filtration rate (GFR), as measured by 24-hour creatinine clearance and clearance of iothalamate, and effective renal plasma flow (ERPF), as measured by the clearance of para-aminohippuric acid (PAH), were evaluated at 2 weeks, 1 month, and 3 months after transplantation in 8 renal transplant patients and at 1 month and 1 year after transplantation in 9 liver transplant patients receiving tacrolimus (Prograf®) therapy. In renal transplant patients, there was a significant increase in GFR after transplantation. There was no change in GFR at 1 and 3 months as compared to 2 weeks after transplantation, while ERPF (ml/min/1.73 m2) was lower (p < 0.05) at 3 months (212 ± 42) compared to 1 month (306 ± 118) after transplantation. In liver transplant patients, GFR and ERPF were below normal despite normal serum creatinine concentrations, but there was no difference in GFR or ERPF at 1 month and 1 year after transplantation. Although below normal, renal function was well preserved in transplant patients while receiving chronic tacrolimus therapy over the study period. Dosage alterations of renally eliminated drugs may be required for drugs with a narrow therapeutic index.

UR - http://www.scopus.com/inward/record.url?scp=0035998758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035998758&partnerID=8YFLogxK

U2 - 10.1177/009127002401102632

DO - 10.1177/009127002401102632

M3 - Article

C2 - 12092747

AN - SCOPUS:0035998758

VL - 42

SP - 798

EP - 805

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 7

ER -